These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4084726)

  • 21. Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Urakami S; Honda S; Shirakawa H; Ishibe T
    J Clin Pathol; 1996 May; 49(5):395-9. PubMed ID: 8707954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of metastatic competence of mouse bladder carcinoma cells after transfection with activated Ha-ras or N-ras oncogenes.
    Pohl J; Radler-Pohl A; Franks LM; Schirrmacher V
    J Cancer Res Clin Oncol; 1988; 114(4):373-9. PubMed ID: 3410877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer.
    Zhau HE; Zhang X; von Eschenbach AC; Scorsone K; Babaian RJ; Ro JY; Hung MC
    Mol Carcinog; 1990; 3(5):254-7. PubMed ID: 1978777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oncogenes in human tumor cell lines: molecular cloning of a transforming gene from human bladder carcinoma cells.
    Pulciani S; Santos E; Lauver AV; Long LK; Robbins KC; Barbacid M
    Proc Natl Acad Sci U S A; 1982 May; 79(9):2845-9. PubMed ID: 6953433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Genomic changes in urinary bladder cancer].
    Sauter G; Moch H; Wagner U; Bubendorf L; Gasser TC; Mihatsch MJ
    Verh Dtsch Ges Pathol; 1997; 81():287-96. PubMed ID: 9474882
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of c-erbB-2 amplification in transitional cell bladder carcinoma using competitive PCR technique.
    Orlando C; Sestini R; Vona G; Pinzani P; Bianchi S; Giacca M; Pazzagli M; Selli C
    J Urol; 1996 Dec; 156(6):2089-93. PubMed ID: 8911396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-jun oncogene expression in transitional cell carcinoma of the urinary bladder.
    Tiniakos DG; Mellon K; Anderson JJ; Robinson MC; Neal DE; Horne CH
    Br J Urol; 1994 Dec; 74(6):757-61. PubMed ID: 7827848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer.
    Montie JE
    J Urol; 2005 Sep; 174(3):869-70. PubMed ID: 16093975
    [No Abstract]   [Full Text] [Related]  

  • 29. Cytogenetic evidence of gene amplification in urothelial cancer--a possible mechanism of tumor invasiveness.
    Milasin J; Mićić S
    Urol Int; 1992; 48(3):258-60. PubMed ID: 1589912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression in superficial bladder cancer in a tumor-model-system (RBT).
    Knopf HJ; von Moorselaar RJ; Debruyne FM; Schalken JA
    Investig Urol (Berl); 1994; 5():76-9. PubMed ID: 7719325
    [No Abstract]   [Full Text] [Related]  

  • 31. Activated H-ras gene mutations in transitional cell carcinoma of urinary bladder in a Kashmiri population.
    Pandith AA; Shah Z; Rasool R; Dil-Afroze ; Yousuf A; Parveen N; Wani S; Siddiqi M
    Tumori; 2010; 96(6):993-8. PubMed ID: 21388064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transfection by human oncogenes: concomitant induction of tumorigenicity and tumor-associated membrane alterations.
    Collard JG; van Beek WP; Janssen JW; Schijven JF
    Int J Cancer; 1985 Feb; 35(2):207-13. PubMed ID: 3855844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic aberrations of the K-ras proto-oncogene in bladder cancer in Kashmiri population.
    Nanda MS; Sameer AS; Syeed N; Shah ZA; Murtaza I; Siddiqi MA; Ali A
    Urol J; 2010; 7(3):168-73. PubMed ID: 20845292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. c-erbB-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder.
    Lunec J; Challen C; Wright C; Mellon K; Neal DE
    Lancet; 1992 Feb; 339(8790):439-40. PubMed ID: 1346710
    [No Abstract]   [Full Text] [Related]  

  • 35. Pathogenicity of retroviruses containing either the normal human c-Ha-ras1 gene or its mutated form derived from the bladder carcinoma EJ/T24 cell line.
    Chang EH; Morgan PL; Lee EJ; Pirollo KF; White EA; Patrick DH; Tsichlis PN
    J Exp Pathol; 1985; 2(3):177-89. PubMed ID: 3842394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma.
    Zhang ZT; Pak J; Shapiro E; Sun TT; Wu XR
    Cancer Res; 1999 Jul; 59(14):3512-7. PubMed ID: 10416618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumorigenic and metastatic properties of "normal" and ras-transfected NIH/3T3 cells.
    Greig RG; Koestler TP; Trainer DL; Corwin SP; Miles L; Kline T; Sweet R; Yokoyama S; Poste G
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3698-701. PubMed ID: 3858844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogene.
    Storer RD; Stein RB; Sina JF; DeLuca JG; Allen HL; Bradley MO
    Cancer Res; 1986 Mar; 46(3):1458-64. PubMed ID: 3510726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the transforming potential of the human H-ras gene by random mutagenesis.
    Fasano O; Aldrich T; Tamanoi F; Taparowsky E; Furth M; Wigler M
    Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4008-12. PubMed ID: 6330729
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent mutations of the p53 gene and infrequent H- and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Yamamoto S; Masui T; Murai T; Mori S; Oohara T; Makino S; Fukushima S; Tatematsu M
    Carcinogenesis; 1995 Oct; 16(10):2363-8. PubMed ID: 7586136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.